3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
110
Sarcoma
58
Lymphoid
9
Gynecologic
3
Genitourinary
3
Gastrointestinal
2
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Head & Neck
1
Endocrine
1
Classical hematology
1
Breast
1
Conditions
Small Cell Lung Carcinoma
16
Carcinoma, Non-Small-Cell Lung
16
Lung Neoplasms
14
Neoplasm Metastasis
7
Brain Neoplasms
7
Sarcoma
2
Melanoma
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Small Cell
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Cancer Recurrent
1
SCLC, Extensive Stage
1
Recurrent Extensive Stage Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Non Small Cell Lung Cancer Metastatic
1
Neuroendocrine Tumors
1
Neoplasms, Second Primary
1
Mesothelioma
1
Extensive Stage Small Cell Lung Cancer
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Neuroendocrine
1
Carcinoma, Large Cell
1
Carcinoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
Paclitaxel
3
Carboplatin
3
selpercatinib
2
Radiotherapy
2
Cisplatin
2
regorafenib
1
pentetreotide
1
pembrolizumab
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
carboxyamido-triazole
1
budigalimab
1
binimetinib
1
aflibercept
1
Trastuzumab
1
Temozolomide
1
Taxes
1
Tamoxifen
1
Quality of Life
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
PF-07284890
1
Nivolumab
1
NEO212
1
Molecular Diagnostic Techniques
1
Midazolam
1
Levofloxacin
1
Lapatinib
1
Ipilimumab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Temozolomide
×
Thoracic
×
Clear all
NCT00629187
2012-04-27
CN-306
Tufts Medical Center
Phase 1
Terminated
2 enrolled